[Federal Register: January 26, 1999 (Volume 64, Number 16)]
[Notices]               
[Page 3956-3957]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26ja99-105]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Institute on Drug Abuse; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as

[[Page 3957]]

amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group Epidemiology and Prevention Research Subcommittee.
    Date: February 9-10, 1999.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Susan L. Coyle, Chief, Clinical, Epidemiological 
and Applied Sciences Review Branch, Office of Extramural Program 
Review, National Institute on Drug Abuse, National Institutes of 
Health, DHHS, 5600 Fishers Lane, Room 10-42, Rockville, MD 20857, 
(301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Epidemiology and Prevention.
    Date: February 10, 1999.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Ritz-Carlton Hotel at Pentagon City, 1250 South Hayes 
Street, Arlington, VA 22202.
    Contact Person: Kesinee Nimit, Health Scientist Administrator, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 5600 Fishers Lane, Room 
10-22, Rockville, MD 20857, (301) 443-9042.

    Name of Committee: National Institute on Drug Abuse Initial 
Review Group Basic Behavioral Science Research Subcommittee.
    Date: February 17-18, 1999.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Contact Person: Mark Swieter, Health Scientist Administrator, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 5600 Fishers Lane, Room 
10-42, Rockville, MD 20857, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Human Brain Project.
    Date: February 23-24, 1999.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Contact Person: Mark Swieter, Health Scientist Administrator, 
Office of Extramural Program Review, National Institute on Drug 
Abuse, National Institutes of Health, DHHS, 5600 Fishers Lane, Room 
10-42, Rockville, MD 20857, (301) 443-2620.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Program Projects.
    Date: February 23, 1999.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Contact Person: Rita Liu, Health Scientist Administrator, Office 
of Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 5600 Fishers Lane, Room 10-22, 
Rockville, MD 20857, (301) 443-9042.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Centers.
    Date: February 24, 1999.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Contact Person: Rita Liu, Health Scientist Administrator, Office 
of Extramural Program Review, National Institute on Drug Abuse, 
National Institutes of Health, DHHS, 5600 Fishers Lane, Room 10-22, 
Rockville, MD 20857, (301) 443-9042.

    Name of Committee: National Institute on Drug Abuse Special 
Emphasis Panel Medication Development.
    Date: February 24, 1999.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Key Bridge Marriott, 1401 Lee Highway, Arlington, VA 
22209.
    Contact Person: Khursheed Asghar, Chief, Basic Sciences Review 
Branch, Office of Extramural Program Review, National Institute on 
Drug Abuse, National Institutes of Health, DHHS, 5600 Fishers Lane, 
Room 10-22, Rockville, MD 20857, (301) 443-2620.

(Catalogue of Federal Domestic Assistance Program Nos. 93.277, Drug 
Abuse Scientist Development Award for Clinicians, Scientist 
Development Awards, and Research Scientist Awards; 93.278, Drug 
Abuse National Research Service Awards for Research Training; 
93.279, Drug Abuse Research Programs, National Institutes of Health, 
HHS)

    Dated: January 19, 1999.
LaVerne Y. Stringfield.
Committee Management Officer, NIH.
[FR Doc. 99-1723 Filed 1-25-99; 8:45 am]
BILLING CODE 4140-01-M